Roll-Mecak, Antonina
- National Institute of Neurological Disorders and Stroke (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #863
- Sustained Excellence
- Top 5% Funded
- Long-Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2007 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2023
Linked Award Amount
$4.6M
Full award amounts, FY2023
Award Records
4
Records listing this PI
Award-Linked Rank
#863
By linked amount among FY2023 PIs
Earliest Year Loaded
2007
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Roll-Mecak, Antonina as a PI. Multi-PI records show the full award amount for context.
- 1ZIANS003164-07ZIAContact PIReadout of the tubulin code by cellular effectors$1.5Maward amount
- 1ZIANS003165-07ZIAContact PIMechanism of microtubule severing enzymes$1.4Maward amount
- 1ZIANS003163-07ZIAContact PIMechanism of tubulin modification enzymes$1.4Maward amount
- 1ZIANS009447-02ZIAContact PI4D map of the tubulin code in the human neuron$387.8Kaward amount
Award organization
Organizations that administered FY2023 awards listing Roll-Mecak, Antonina as a PI.
FY2023 award administered by National Institute of Neurological Disorders and Stroke ().
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2007First NIH AwardNational Institute of Neurological Disorders and Stroke
- 2010$500K Cumulative Funding
- 2010$1M Cumulative Funding
- 2010Entered Top 50% NationallyRanked #6349
- 2011$2M Cumulative Funding
- 2011Entered Top 25% NationallyRanked #4960
- 2013$5M Cumulative Funding
- 2016$10M Cumulative Funding
- 2017Entered Top 10% NationallyRanked #1611
- 2021Entered Top 5% NationallyRanked #969
- 2022$25M Cumulative Funding